Hybrid Group Singing

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-89
SponsorMedical College of Wisconsin

About this trial

The overall objective of the planned future clinical trial is to test the investigator's central hypothesis that habitual singing over several weeks, similar to habitual exercise, will lead to sustained and favorable vascular adaptation, thereby lowering cardiovascular disease (CVD) risk. The overall objective of this study is to refine and protocolize the singing interventions and test the feasibility of the future trial design. The investigative team has previously studied solo singing. Collective singing, as in a choir or small group, is associated with a positive sense of social inclusion, well-being, and improved mood, including in older adults.

Eligibility criteria

Qualifiers

history of coronary artery disease (defined as having at least 1 of the following: myocardial infarction, coronary stent, PCI, CABG, coronary stenosis at least 50%, or coronary artery calcification score at least 300 Agatston units)

Disqualifiers

Parkinson's disease or tremor

upper arm fistula

fingernail onychomycosis

pregnancy

Trial design

Treatments tested in this trial

  • group singing (hybrid format)
  • instructional sing-along video series

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators